Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |